Parent Project Muscular Dystrophy Funds $250K CRISPR Grant for UT-Southwestern

Jan 30, 2017

|

NEW YORK (GenomeWeb) – Parent Project Muscular Dystrophy today announced it has granted $250,000 to University of Texas Southwestern Medical Center researcher Eric Olson for his study of a CRISPR/Cas9-based treatment for Duchenne muscular dystrophy (DMD).

Olson said in a statement that he would use the funding to test the effectiveness and safety of CRISPR in animal models of DMD. The lab will study dystrophin proteins produced using genome editing in mice and compare them to dystrophin produced by other therapeutic approaches, such as gene transfer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Better Recovery

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

Science 'Critical Thinking' Bill in South Dakota

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

This Week in Science

In Science this week: the synthetic genetic system hachimoji, and more.

No More

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.

Featured White Papers

Controlling Ribonuclease (RNase) with High Irradiance UV LED Light Engines

The Ultimate Guide to Mouse Clinical Trials

High Throughput RT-qPCR for Gene Expression Analysis

Mar

21

Featured Webinar

A Long-Read vs. Short-Read Platform Comparison (Part 2): Best NGS Approaches for Human Transcriptome Sequencing

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Main menu